Oct. 20 at 5:48 PM
$CRDL Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics
October 15, 2025 — @ZacksResearch
For Immediate Release
Chicago, IL – October 15, 2025 – Zacks Equity Research discusses Akebia Therapeutics
$AKBA, Ironwood Pharmaceuticals
$IRWD, Pyxis Oncology
$PYXS, Cardiol Therapeutics
$CRDL and Plus Therapeutics
$PSTV.
Industry: Drugs (non-Big Pharma)
Link: https://zacks.com/commentary/2767977/5-small-drug-stocks-to-buy-as-the-industry-shows-some-recovery